Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
Jackson Jeikai LiangMelissa A ElafrosMichael T MullenDaniele MuserTatsuya HayashiAndres EnriquezRajeev K PathakErica S ZadoPasquale SantangeliJeffrey S ArklesRobert D SchallerGregory E SuppleDavid S FrankelFermin C GarciaRajat DeoDavid LinMichael P RileySaman NazarianSanjay DixitFrancis E MarchlinskiDavid J CallansPublished in: Journal of cardiovascular electrophysiology (2018)
Anticoagulation discontinuation in well selected, closely monitored patients following successful ablation of nonparoxysmal AF was associated with a low rate of clinical embolic CVEs. Prospective studies are required to confirm safety of OAT discontinuation after successful AF ablation.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- end stage renal disease
- heart failure
- newly diagnosed
- ejection fraction
- percutaneous coronary intervention
- chronic kidney disease
- peritoneal dialysis
- patient reported outcomes
- coronary artery disease
- mitral valve